Skip to content

Opioid requirement between intravenous nalbuphine and morphine for postoperative analgesia after cesarean section under spinal anesthesia

Opioid requirement between intravenous nalbuphine and morphine for postoperative analgesia after cesarean section under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210903005
Enrollment
160
Registered
2021-09-03
Start date
2022-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy term pregnant woman Postoperative pain Spinal anesthesia Nalbuphine

Interventions

IV PCA nalbuphine,IV PCA morphine
Experimental Drug,Experimental Drug
Nalbuphine group,Morphine group

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Term pregnancy with - Age more than18 years - Patient ASA physical status I-III. - Scheduled for elective cesarean section under spinal anesthesia - Can operate a patient-controlled analgesia (PCA) device.

Exclusion criteria

Exclusion criteria: - Known hypersensitivity to researched drugs - History of chronic pain - History of drug addict use - Patient refuse for spinal anesthesia - Medical complications eg heart diseases, diabetes, hypertension, renal or hepatic disease, obesity >=100 kilograms - Gynecological complications eg myoma uteri, ovarian tumors - Obstetrical complications eg multiple gestation, pre-eclampsia, fetal distress, IUGR(intra-uterine growth retardation), placenta previa

Design outcomes

Primary

MeasureTime frame
Postoperative morphine and nalbuphine consumption 24 hours milligram

Secondary

MeasureTime frame
Numerical rating scale 6, 12 , 24 hour point,Nausea and vomiting 6,12,24 hour 0-3 point,Pruritus score 6,12,24 hour 0-3 point,Respiratory depression 6 12 24 hour Sedation score 0-3

Countries

Thailand

Contacts

Public ContactJEDSADAYOOT SAKAROONCHAI

Thammasat University

jed_v6@hotmail.com66814453572

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026